HomeCompareCURZ vs JNJ

CURZ vs JNJ: Dividend Comparison 2026

CURZ yields 160.00% · JNJ yields 2.13%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 CURZ wins by $34.83M in total portfolio value
10 years
CURZ
CURZ
● Live price
160.00%
Share price
$1.25
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$34.86M
Annual income
$15,634,271.53
Full CURZ calculator →
JNJ
Johnson & Johnson
● Live price
2.13%
Share price
$244.44
Annual div
$5.20
5Y div CAGR
28%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$30.3K
Annual income
$4,689.40
Full JNJ calculator →

Portfolio growth — CURZ vs JNJ

📍 CURZ pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodCURZJNJ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, CURZ + JNJ cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
CURZ pays
JNJ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

CURZ
Annual income on $10K today (after 15% tax)
$13,600.00/yr
After 10yr DRIP, annual income (after tax)
$13,289,130.80/yr
JNJ
Annual income on $10K today (after 15% tax)
$180.82/yr
After 10yr DRIP, annual income (after tax)
$3,985.99/yr
At 15% tax rate, CURZ beats the other by $13,285,144.81/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of CURZ + JNJ for your $10,000?

CURZ: 50%JNJ: 50%
100% JNJ50/50100% CURZ
Portfolio after 10yr
$17.44M
Annual income
$7,819,480.46/yr
Blended yield
44.83%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

CURZ
No analyst data
JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
-6.4% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

CURZ buys
0
JNJ buys
8
PoliticianChamberTickerTypeAmountDate
Thomas H. Kean🏢 House$JNJ▼ Sell$15,001 - $50,0002026-01-23
Julie Johnson🏢 House$JNJ▼ Sell$1,001 - $15,0002025-12-18
Lloyd Doggett🏢 House$JNJ▲ Buy$1,001 - $15,0002025-12-09
Thomas H. Kean🏢 House$JNJ▼ Sell$15,001 - $50,0002025-11-20
Julie Johnson🏢 House$JNJ▼ Sell$1,001 - $15,0002025-11-13
Rich McCormick🏢 House$JNJ▲ Buy$1,001 - $15,0002025-11-05
Ro Khanna🏢 House$JNJ▲ Buy$1,001 - $15,0002025-10-30
Ro Khanna🏢 House$JNJ▲ Buy$1,001 - $15,0002025-10-30
Ro Khanna🏢 House$JNJ▲ Buy$1,001 - $15,0002025-10-30
Jared Moskowitz🏢 House$JNJ▼ Sell$1,001 - $15,0002025-10-10
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricCURZJNJ
Forward yield160.00%2.13%
Annual dividend / share$2.00$5.20
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%28%
Portfolio after 10y$34.86M$30.3K
Annual income after 10y$15,634,271.53$4,689.40
Total dividends collected$32.40M$15.4K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: CURZ vs JNJ ($10,000, DRIP)

YearCURZ PortfolioCURZ Income/yrJNJ PortfolioJNJ Income/yrGap
1← crossover$26,700$16,000.00$10,592$272.30+$16.1KCURZ
2$68,494$39,925.23$11,289$357.73+$57.2KCURZ
3$169,010$95,720.83$12,123$472.89+$156.9KCURZ
4$401,580$220,739.56$13,141$629.86+$388.4KCURZ
5$919,872$490,181.40$14,408$846.81+$905.5KCURZ
6$2,033,632$1,049,369.50$16,021$1,151.60+$2.02MCURZ
7$4,344,139$2,168,152.23$18,122$1,588.22+$4.33MCURZ
8$8,976,727$4,328,498.22$20,930$2,228.20+$8.96MCURZ
9$17,964,357$8,359,258.83$24,792$3,191.91+$17.94MCURZ
10$34,856,133$15,634,271.53$30,274$4,689.40+$34.83MCURZ

CURZ vs JNJ: Complete Analysis 2026

CURZStock

Curzio Research, Inc. publishes financial newsletters in the United States. Its newsletters provide market analysis and stock ideas, and tools for individual investors. The company offers various publications, such as Curzio Research Advisory, an investment newsletter; Curzio Venture Opportunities, a small-cap newsletter advisory; Crypto Intelligence; Moneyflow Trader; the Dollar Stock Club; Unlimited Income, an income asset advisory; the Big Money Report; and Big Money Trader, as well as Wall Street Unplugged, a financial podcast. Curzio Research, Inc. was founded in 2016 and is based in Fernandina Beach, Florida.

Full CURZ Calculator →

JNJHealthcare

Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.

Full JNJ Calculator →
📬

Get this CURZ vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

CURZ vs SCHDCURZ vs JEPICURZ vs OCURZ vs KOCURZ vs MAINCURZ vs ABBVCURZ vs MRKCURZ vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.